Skip to content

TASI 8150 · Insurance · ACIG

Statement of Changes in Equity

H1 / Q2 2023
Open full interactive statement

Equity movements

MovementTotal equitySAR thousands
2023 equity movements
Balance at 1 January 2023 as previously reported162,311
Transition adjustment on initial application of IFRS 17(11,094)
Transition adjustment on initial application of IFRS 937,693
Restated balance at 1 January 2023188,910
Sale of FVOCI investments-
Net income attributable to shareholders14,063
Total comprehensive income for the period14,063
Balance at 2023-06-30202,973
2022 equity movements
Balance at 1 January 2022 as previously reported32,036
Transition adjustment on initial application of IFRS 17(6,856)
Transition adjustment on initial application of IFRS 934,830
Restated balance at 1 January 202260,010
Change in fair value reserve on available-for-sale investments-
Increase in share capital through rights issue150,000
Net loss attributable to shareholders(33,612)
Total comprehensive income (loss) for the period116,388
Balance at 2022-06-30176,398
Figures follow the filing’s original columns.
Page 8 ↗

The equity statement reports a different restated January 2023 opening balance from the balance sheet and presents prior-period OCI differently from the comprehensive income statement. Values are shown as published in each statement. Published equity and OCI presentation · Page 8 ↗

Available periods 35